These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8865269

  • 61. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV, Kravchuk GP, Kazirchuk VE, Maksiuk LV, Zabolotnyĭ DI.
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract] [Full Text] [Related]

  • 62. [Levamisole as an immunostimulant in primary lung cancer].
    Krzyśko R, Słowik-Gabryelska A.
    Pneumonol Pol; 1981 Jan; 49(1):29-34. PubMed ID: 7291005
    [No Abstract] [Full Text] [Related]

  • 63. [Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)].
    Miyake M.
    Fukuoka Igaku Zasshi; 1981 Jun; 72(6):368-78. PubMed ID: 6975743
    [No Abstract] [Full Text] [Related]

  • 64. [Current indications for levamisole].
    Matkovics A.
    Orv Hetil; 2004 Oct 31; 145(44):2259-60. PubMed ID: 15626175
    [No Abstract] [Full Text] [Related]

  • 65. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
    García Camín RM, Cabezas A, Calero F, Ballarín JA.
    Nefrologia; 2004 Oct 31; 24 Suppl 3():68-71. PubMed ID: 15219073
    [Abstract] [Full Text] [Related]

  • 66. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb 31; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 67. Levamisole in nephrotic syndrome.
    Srivastava RN, Vasudev AS, Bagga A.
    Lancet; 1991 Nov 16; 338(8777):1275. PubMed ID: 1682671
    [No Abstract] [Full Text] [Related]

  • 68. [Levamisole and its use in dermatologic therapy].
    Marcyniak-Górska M.
    Przegl Dermatol; 1983 Nov 16; 70(5-6):563-8. PubMed ID: 6366926
    [No Abstract] [Full Text] [Related]

  • 69. A male patient with steroid-dependent nephrotic syndrome for 25 years and obesity-associated focal segmental glomerulosclerosis.
    Motoyama O, Muto A, Ogiwara H, Mizuiri S, Kawamura S, Iitaka K.
    Clin Exp Nephrol; 2004 Sep 16; 8(3):263-5. PubMed ID: 15480905
    [Abstract] [Full Text] [Related]

  • 70. [Selectivity of proteinuria in nephrotic syndrome in children].
    Wojnarowski M, Markocki Z, Janecki J.
    Pediatr Pol; 1972 Nov 16; 48(11):1341-4. PubMed ID: 4647893
    [No Abstract] [Full Text] [Related]

  • 71. Cyclophosphamide for nephrotic syndrome in children.
    Br Med J; 1969 Mar 15; 1(5645):660-1. PubMed ID: 5774311
    [No Abstract] [Full Text] [Related]

  • 72. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
    Sun A, Wang JT, Chia JS, Chiang CP.
    J Oral Pathol Med; 2006 Feb 15; 35(2):111-6. PubMed ID: 16430742
    [Abstract] [Full Text] [Related]

  • 73. Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children.
    Demirci F, Bayraktaroğlu Z, Karaoğlan M, Coşkun Y, Karaoğlan I, Okan V.
    Turk J Gastroenterol; 2005 Dec 15; 16(4):188-93. PubMed ID: 16547845
    [Abstract] [Full Text] [Related]

  • 74. Generalized lichen nitidus in a child's response to cetirizine dihydrochloride/levamisol.
    Sehgal VN, Jain S, Kumar S, Bhattacharya SN, Singh N.
    Australas J Dermatol; 1998 Feb 15; 39(1):60. PubMed ID: 9529696
    [No Abstract] [Full Text] [Related]

  • 75. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
    Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ.
    Nephrol Dial Transplant; 2004 May 15; 19(5):1136-41. PubMed ID: 14993510
    [Abstract] [Full Text] [Related]

  • 76. [Indomethacin in the treatment of the nephrotic syndrome and residuaproteinuria].
    Murisasco A, Picon G, Hebreard J, Sansot M, Aubert L, Taramasco J, Mrtin J, Manassero L.
    Mars Med; 1967 May 15; 104(9):787-91. PubMed ID: 5619524
    [No Abstract] [Full Text] [Related]

  • 77. [Effect of heparin on proteinuria and other biochemical parameters in nephrotic syndrome].
    Poplawski A.
    Pol Tyg Lek; 1974 Mar 15; 29(10):289-91. PubMed ID: 4826144
    [No Abstract] [Full Text] [Related]

  • 78. Levamisole, immunostimulation, and the acquired immunodeficiency syndrome.
    Surapaneni N, Raghunathan R, Beall GN, Daniel K, Mundy TM.
    Ann Intern Med; 1985 Jan 15; 102(1):137. PubMed ID: 3966738
    [No Abstract] [Full Text] [Related]

  • 79. FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy.
    De Smet E, Rioux JP, Ammann H, Déziel C, Quérin S.
    Nephrol Dial Transplant; 2009 Sep 15; 24(9):2938-40. PubMed ID: 19509024
    [Abstract] [Full Text] [Related]

  • 80. [Immunostimulation with levamisole in the treatment of children with neoplasms].
    Newecka-Samól T, Ochocka M.
    Pediatr Pol; 1981 Sep 15; 56(9):1065-70. PubMed ID: 6948271
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.